| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/01/1991 | CA2022114A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022112A1 Certain imidazole compounds as transglutaminase inhibitors |
| 01/31/1991 | DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability |
| 01/30/1991 | EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. |
| 01/30/1991 | EP0410671A1 Acylated epidermal growth factor |
| 01/30/1991 | EP0410661A2 Bicyclic derivatives |
| 01/30/1991 | EP0410641A2 Dopamine agonists |
| 01/30/1991 | EP0410409A1 3,5-Dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| 01/30/1991 | EP0410389A1 Indolocarbazol and its use |
| 01/30/1991 | EP0410379A2 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins |
| 01/30/1991 | EP0410244A1 Leukotriene antagonists |
| 01/30/1991 | EP0410006A1 Eye drops for healing wound of corneal epithelium |
| 01/30/1991 | EP0409845A1 Method for protection from chemotherapeutic side effects |
| 01/30/1991 | EP0298121A4 Biocompatible material for treatment of defects in tissues and organs |
| 01/29/1991 | US4988735 Artheriosclerosis, cardiovascular disorders, trimethoxybenzyl-N'-3,3-di-4-fluorophenyl-propyl-ethylenediamine |
| 01/29/1991 | US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents |
| 01/29/1991 | US4988707 Pharmacologically active phenylalkanoyl substituted imidazo (4,5-C) pyridines |
| 01/29/1991 | US4988701 Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions |
| 01/29/1991 | US4988692 Cholecystokinine antagonist as analgesics, hyperglycemics, gastrointestinal disorders |
| 01/29/1991 | US4988691 Analgesics, cardiovascular disorders, nervous system disorders |
| 01/29/1991 | US4988680 Phosphorylase inhibitors, immuno suppressants, parasiticides, antileukemia agents |
| 01/29/1991 | US4988678 Combinations of FU and BVU as anti-adenocarcinoma agents |
| 01/29/1991 | CA1279651C Orally active phosphonyl hydroxyacyl prolines and processes for preparing phosphonyl hydroxyacyl prolines |
| 01/28/1991 | CA2021996A1 Leukotriene antagonists |
| 01/28/1991 | CA2018469A1 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| 01/25/1991 | CA2021314A1 Dopamine agonists |
| 01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
| 01/24/1991 | WO1991000733A1 Method of treatment of androgen-related diseases |
| 01/24/1991 | WO1991000731A1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 01/24/1991 | WO1991000710A1 Treatment of bone disorders |
| 01/24/1991 | WO1990009163A3 Method and compounds for aica riboside delivery and for lowering blood glucose |
| 01/24/1991 | DE3924365A1 2-amino-7-carbamoyl-1,2,3,4- tetrahydronaphthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel 2-amino-7-carbamoyl-1,2,3,4 tetrahydronaphthalenes, process for their production and their use as drug |
| 01/24/1991 | DE3923797A1 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-fluoro-prostaglandin derivatives, to processes for their preparation and their pharmaceutical use |
| 01/23/1991 | WO1991001297A1 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, process for preparing them and their use as drugs |
| 01/23/1991 | EP0409812A2 Fucosidase inhibitor |
| 01/23/1991 | EP0409676A1 Novel acetylcholinesterase inhibitors |
| 01/23/1991 | EP0409472A1 Bone morphogenetic protein |
| 01/23/1991 | EP0409414A1 Diaryl ether cycloalkanes |
| 01/23/1991 | EP0409413A2 Diaryl ether heterocycles |
| 01/23/1991 | EP0409412A2 Diaryl ether cyclic ethers |
| 01/23/1991 | EP0409410A1 Indenoindole compounds |
| 01/23/1991 | EP0409406A2 Aryl-substituted amine derivatives useful in cancer therapy |
| 01/23/1991 | EP0409392A2 Compositions and method for treatment of mast cell-mediated dermatologic disorders using nalmefene |
| 01/23/1991 | EP0409332A2 Substituted triazoles as angiotensin II antagonists |
| 01/23/1991 | EP0409281A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 01/23/1991 | EP0409163A2 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors |
| 01/23/1991 | EP0409048A2 Aminoalkyl substituted 2-aminothiazoles and medicines containing them |
| 01/23/1991 | EP0409027A1 Indole derivatives, process for their preparation and their use in pharmaceuticals |
| 01/23/1991 | EP0408650A1 Method and composition for treating neurological disorders |
| 01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
| 01/23/1991 | CA2033323A1 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, processes for their preparation and their use as medicaments |
| 01/22/1991 | CA2021560A1 Indole derivatives, a process for their preparation and their use in medicaments |
| 01/22/1991 | CA1279317C Piperidine derivative and pharmaceutical composition |
| 01/20/1991 | CA2021255A1 Substituted triazoles as angiotensin ii antagonists |
| 01/20/1991 | CA2020729A1 Bone morphogenetic protein |
| 01/19/1991 | CA2020288A1 Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them |
| 01/18/1991 | CA2019543A1 Diaryl ether cyclic ethers |
| 01/18/1991 | CA2019345A1 Diaryl ether heterocycles |
| 01/18/1991 | CA2019344A1 Diaryl ether cycloalkanes |
| 01/17/1991 | DE3943519A1 Treatment of erectile dysfunction - with peptide aspartic-acid -leucine -glutamine -alanine |
| 01/17/1991 | DE3923798A1 (delta)(pfeil hoch)8(pfeil hoch)-und(delta)(pfeil hoch)9(pfeil hoch)-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung (Delta) (arrow up) 8 (arrow up) -and (delta) (arrow up) 9 (arrow up) -prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/16/1991 | EP0408509A2 Substituted benzonitriles |
| 01/16/1991 | EP0408284A2 Amylin for treatment of bone disorders |
| 01/16/1991 | EP0408273A1 Fosinopril tablet formulations |
| 01/16/1991 | EP0407844A1 Indole derivatives |
| 01/16/1991 | EP0407780A2 Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult |
| 01/16/1991 | EP0407416A1 Therapeutically useful tetralin derivatives |
| 01/16/1991 | CN1048546A Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists |
| 01/15/1991 | WO1991001303A1 Δ8 and Δ9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 01/15/1991 | WO1991001302A1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 01/15/1991 | US4985447 Certain benzoquinones, naphthoquinones and derivatives thereof which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like |
| 01/15/1991 | US4985444 Pyrazolopyridine compound and processes for preparation thereof |
| 01/15/1991 | US4985437 Medicaments |
| 01/15/1991 | US4985427 Triazine derivatives |
| 01/15/1991 | US4985424 Certain substituted 1,7-annelated 1h-indazoles being selective antagonists of 5-ht-receptors |
| 01/15/1991 | US4985422 Tricyclic, imidazole substituted, antagonist of hydroxytryptamine receptors, psychotic disorders, schizophrenia |
| 01/15/1991 | US4985420 1,7-annelated indolecarboxylic acid esters and -amides |
| 01/15/1991 | US4985417 Treatment of glaucoma |
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | US4985405 Therapeutic product based on organic silicon derivatives |
| 01/15/1991 | CA2036386A1 9-fluoroprostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/15/1991 | CA2036383A1 8-and 9-prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/15/1991 | CA2021049A1 Substituted benzonitriles |
| 01/14/1991 | WO1991001123A2 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d¿4? |
| 01/14/1991 | CA2036384A1 Modified transforming growth factor ó oligopeptides and pharmaceutical compositions thereof |
| 01/14/1991 | CA2036381A1 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d4 |
| 01/14/1991 | CA2020936A1 Indole derivatives |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000274A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407345A2 Topical formulations |
| 01/09/1991 | EP0407344A2 Pharmaceutical preparation for topical application |
| 01/09/1991 | EP0407342A2 Pyrimidine derivatives |
| 01/09/1991 | EP0407102A1 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists |
| 01/09/1991 | EP0407017A1 Epoxysuccinic acid derivatives useful as specific inhibitors of cathepsin B |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406614A1 Sulfamoylthiophenes, a process for their preparation, and their use |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |